[New therapeutic data in inflammatory colitis].
Karsenti
P
P
D000636:Aminosalicylic Acids / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D019819:Budesonide; D003092:Colitis / Q000188:drug therapy* / Q000601:surgery; D003093:Colitis, Ulcerative / Q000188:drug therapy / Q000601:surgery; D003424:Crohn Disease / Q000188:drug therapy / Q000601:surgery; D016572:Cyclosporine / Q000627:therapeutic use; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D019804:Mesalamine; D008727:Methotrexate / Q000627:therapeutic use; D011282:Pregnenediones / Q000627:therapeutic use
D000636:Aminosalicylic Acids; D000893:Anti-Inflammatory Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D011282:Pregnenediones; D019804:Mesalamine; D019819:Budesonide; D016572:Cyclosporine; C032587:olsalazine; D008727:Methotrexate
Nouvelles données thérapeutiques dans les colites inflammatoires.